Trial · NCT02536846
Results by group65
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 65
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change in Brain Nicotinamide Adenine Dinucleotide Metabolites NAD+/NADH | Olanzapine | -0.79 | Standard Deviation 2.37 | ratio | |
| Change in Brain Phosphocreatine (PCr) | Olanzapine | 0.01 | Standard Deviation 0.11 | ratio | |
| Change in Brain Creatine Kinase (CK) Forward Reaction Rate | Olanzapine | -0.04 | Standard Deviation 0.08 | s-1 | |
| Change in Brain Parenchymal pH | Olanzapine | 0.00 | Standard Deviation 0.01 | pH | |
| Change in Volumes of the Frontal, Parietal and Temporal Lobe Regions | Olanzapine | Frontal Lobe | -2500.44 | Standard Deviation 4304.17 | cubic mm |
| Change in Volumes of the Frontal, Parietal and Temporal Lobe Regions | Olanzapine | Parietal Lobe | -600 | Standard Deviation 1264.79 | cubic mm |
| Change in Surface Area of the Frontal, Parietal and Temporal Regions | Olanzapine | Frontal lobe | -801.19 | Standard Deviation 1563.02 | mm^2 |
| Change in Surface Area of the Frontal, Parietal and Temporal Regions | Olanzapine | Parietal lobe | -581.56 | Standard Deviation 1272.93 | mm^2 |
| Change in fMRI Resting State Functional Connectivity | Olanzapine | medial prefrontal cortex | 0 | Voxels | |
| Change in fMRI Resting State Functional Connectivity | Olanzapine | superior parietal lobule | 0 | Voxels | |
| Change in GABA Concentration | Olanzapine | 0.11 | Standard Deviation 0.20 | mmol | |
| Change in Fractional Anisotropy (FA) Measured by Diffusion Tensor Imaging (DTI) | Olanzapine | Core FA | 0.0007 | Standard Deviation 0.01 | Units on a scale |
| Change in Fractional Anisotropy (FA) Measured by Diffusion Tensor Imaging (DTI) | Olanzapine | Genu of corpus callosum | -0.003 | Standard Deviation 0.013 | Units on a scale |
| Change in Fractional Anisotropy (FA) Measured by Diffusion Tensor Imaging (DTI) | Olanzapine | Cingulum | -0.008 | Standard Deviation 0.027 | Units on a scale |
| Change in Fractional Anisotropy (FA) Measured by Diffusion Tensor Imaging (DTI) | Olanzapine | Inferior fronto-occipital fasciculus | -0.002 | Standard Deviation 0.012 | Units on a scale |
| Change in Fractional Anisotropy (FA) Measured by Diffusion Tensor Imaging (DTI) | Olanzapine | Anterior thalamic radiation | 0.002 | Standard Deviation 0.015 | Units on a scale |
| Change in Glutamate Metabolite Concentration | Olanzapine | 0.13 | Standard Deviation 0.66 | millimoles | |
| Change in MATRICS Cognitive Consensus Battery (MCCB) Total Composite Score | Olanzapine | 3.63 | Standard Deviation 4.72 | Score on a scale | |
| Change in Montgomery-Asberg Depression Rating Scale (MADRS) Score | Olanzapine | -0.88 | Standard Deviation 3.00 | score on a scale | |
| Change in Beck Depression Inventory (BDI) Score | Olanzapine | -0.63 | Standard Deviation 1.30 | score on a scale |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02536846/results